URO TODAY: A relatively new, non-invasive and side effect-free way to treat prostate cancer – using a light-activated drug and lasers – is being used more often in the US and Europe. READ MORE>
During the procedure, laser fibres are positioned over the prostate where cancer cells have been identified.
Once in place, a photo-sensitising drug called WST11 is administered to the patient intravenously and circulates throughout the bloodstream for 10 minutes.
The laser fibres are then activated to deliver a specific wave-length of light to the prostate for 20 minutes.
When the light comes into contact with the drug in circulation, the laser fibres destroy the blood vessels around the tumour, shutting down blood supply to the cancer.